Tenn.; 8-wk-old nonresponding (CBA/N × BALB/c male)F1 (xid +, CB mice) and responding (BALB/c × CBA/N male)Fx (xid-, BC mice) were obtained from the Division of Research Services, National Institutes of Health, Bethesda, Md. Mice were bled from the retro-orbital plexus before killing and cell fusion for the measurement of serum antibody levels.
Immunizations. Mice were given an optimally immunogenic dose (0.5/*g) of SSS-III i.p.; 2 d later, they were given 300/*g concanavalin A (Con A) i.p. in saline (6) . Mice were killed 5 d after immunization.
Cell Fusion. Hybridomas were produced as described by Margulies et al. (7) with slight modifications (K. Jin Kim and K. R. Schroer. Manuscript in preparation.). Pooled spleen-cell suspensions from four immunized mice were fused with polyethylene glycol to the NS1 plasmacytoma cell line of X63 (8) . Fusion products were then cloned at a limiting dilution of 5 2 × 10 cultured spleen cells per well in 96-well plates (Costar, Data Packaging, Cambridge, Mass.). Culture supernates were assayed for antibody specific for SSS-III, at day 14, after fusion and subsequent culture.
Antibody Assays. Sera of immunized mice were tested for antibody specific for SSS-III by a 125 modified Farr assay using 14% polyethylene glycol (mol wt, 6,000) to precipitate antibody-I-SSS-III complexes. Cell-culture supernates were assayed for antibody by radioimmunometric binding of 12SI-anti-Fab, (or iodinated anti-/*, anti-a, anti-yl, or anti-y2) to antigen-coated (SSS-III) polyvinyl chloride flexible microtiter plates (Cooke Engineering Co., Alexandria, Va.) (9) . Binding in the radioimmunometric assays was >95% inhibitable with SSS-III. Results and Discussion Serum antibody titers from immunized mice are compared in Fig. 1 . Nonresponding CB mice bearing the X-linked genetic defect showed no detectable binding to SSS-III, whereas responding BC and BALB/c mice give rather typical binding curves (ABC 20:1/81-1/243). CB sera were shown by 125I-anti-Fab binding to contain <20 ng/ml of anti-SSS-III antibody. Thus, significant amounts of antibody were not detectable in the serum of defective mice.
Spleen cells from hemizygous F1 male mice were then fused to plasmacytoma cells after the mice were immunized with SSS-III and treated with Con A to optimize any expression of B-cell activity (6) . The analysis of cell-culture supernatant fluids from cloned fusion products for binding to SSS-III was performed at 14 d. At that time, all clones were grown continuously in the presence of HAT (hypoxanthine, aminopterin, thymidine) to select for hybrids. This also ensures that the X chromosome derived from immunized spleen cells is present in the hybrid-cell heterokaryons because the X chromosome (HGPRT ÷, xid ÷) from the spleen-cells population provides protection against the lethal effects of HAT on parental myeloma cells, NSI (HGPRT-, xid-). The analysis of positive and negative wells is shown in Table I for anti-# specificity. Thus, 16 culture supernates gave binding comparable to levels obtained by specific dilutions of an affinity purified hybridoma standard (IgM, •) that is maintained in 5,000-10,000 1 0 100 ng/ml 10,000-15,000 1 3 --15,000-20,000 0 0 1 ~g/ml 20,000-25,000 2 0 --25,000-35,000 0 4 10/tg/ml * 0.010 ml of culture supernate from CB or BC mice hybridoma cultures were tested with 100,000 cpm '251-anti-# for solid-phase binding to plastic plates. :l: Affinity purified hybridoma (BALB/c, IgM, ~) anti-SSS-III (DB6-1).
our laboratory. Similar analyses were performed for other isotypes. The frequency and isotype distribution of the hybrids obtained is shown in Table II . Although the numbers are small and the frequency distributions are difficult to compare, a striking finding is the presence of SSS-III-specific hybrids from nonresponder, defective mice. In fact, the amount of antibody detected in culture fluids from such hybrids ranged from 10 ng/ml to 10/tg/ml. This occurred despite the fact that serum antibody can not be detected in the serum of such mice before cell fusion (Fig. 1) .
The frequency of antigen-specific fusion products from nonimmunized mice is expected to be nearly zero. For another antigen, sheep erythrocyte (SRBC), it was thought highly unusual to obtain an antigen-specific frequency of 10% among hybrids making antibody specific for SRBC as described by Milstein et al. (8) . Thus, they suggested that antigen-driven activation of B lymphocytes was the essential selective mechanism in generating a high fusion rate (10%). A 5% frequency using CB mice suggests that antigen-driven lymphocyte activation is indeed occurring, even if no specific evidence for such activation (the presence of serum antibody) is evident in vivo. This implies that the B cells of mice bearing the X-linked genetic defect possess antigen-specific receptors through which activation occurs. The reason why such activation is not expressed as antibody synthesis in mice bearing the X-linked genetic defect is not known, although there are several possibilities. If an intracellular mechanism for the assembly and/or export of immunoglobulin is defective, then the hybrid-partner cell (the NS1 plasma-cell tumor) may be reconstituting this defect. This would imply the existence of separate pathways for synthesis, assembly, and secretion of antibody when B cells are selected by TI-1 or TI-2 antigens. Immune suppressive regulation of secretion seems to be an unlikely possibility because others have clearly shown that B-cell responses may be transferred adoptively into defective mice (5, 10) . Furthermore, speculation (11, 12) that VH-gene expression is defective in conjunction with the inability to elaborate CH genes commonly associated with polysaccharides (i.e., IgM and IgG3) seems unlikely because all eight isolated hybrids were IgM. The lack of hybrids of other classes should be interpreted cautiously because the number was small. (IgG3 assays were not performed in this investigation.) Whatever the mechanisms involved, the ability to generate hybrids from mice having a completely defective expressed repertoire to particular antigens suggests that hybridization must be used carefully to evaluate the expressed vs. the potential repertoire of antibody-forming cells.
Summary
(CBA/N X BALB/c male)F1 mice bear on X-linked defect making them totally unresponsive to T-independent (TI), TI-2 antigens such as type III pneumococcal polysaccharide (SSS-III). We found that somatic cell hybrids between CB nonresponder spleen cells and NS1 plasmacytoma cells secreted antibody specific for SSS-III. The solid-phase binding of such antibody was completely inhibited by the addition of free antigen (SSS-III) and the amount of antibody detected in culture fluids ranged from 10 ng/ml to 10 btg/ml. Eight hybridoma clones were identified; all make antibody of the IgM class. These results indicate that the X-linked defect does not result in a deletion of a B-cell subset which responds to TI-2 antigens.
